BioNTech founder suggests vaccine could lead to 'normal winter' in 2021


Ugur Sahin, the co-founder of BioNTech, warned the current winter "will be hard," but the next one could be much smoother "if everything continues to go well" with his company's coronavirus vaccine candidate.
Sahin told the BBC on Sunday that the vaccine, which is being co-developed with Pfizer and was found to be 90 percent effective in an interim trial analysis, likely won't immediately bring down infection numbers if it's unveiled later this year, but he believes "we could have a normal winter" in 2021. The plan, he said, is to deliver 300 million doses worldwide by April, which should begin to curb the spread of the virus, and after that it will be "absolutely essential" to "get a high vaccination rate before autumn/winter next year."
Sahin said he's "confident" that will be the case thanks to the number of vaccine companies helping Pfizer and BioNTech increase the supply. Read more at BBC and Politico. Tim O'Donnell
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
What will bring Vladimir Putin to the negotiating table?
Today's Big Question With diplomatic efforts stalling, the US and EU turn again to sanctions as Russian drone strikes on Poland risk dramatically escalating conflict
-
Why social media is obsessed with cortisol
In The Spotlight Wellness trend is the latest response to an increasingly maligned hormone
-
Peter Mandelson called Epstein his 'best pal' in birthday note
Speed Read The UK's ambassador to Washington described the late convicted paedophile as an 'intelligent, sharp-witted man'
-
Google avoids the worst in antitrust ruling
Speed Read A federal judge rejected the government's request to break up Google
-
Supreme Court allows social media age check law
Speed Read The court refused to intervene in a decision that affirmed a Mississippi law requiring social media users to verify their ages
-
Nvidia hits $4 trillion milestone
Speed Read The success of the chipmaker has been buoyed by demand for artificial intelligence
-
X CEO Yaccarino quits after two years
Speed Read Elon Musk hired Linda Yaccarino to run X in 2023
-
Musk chatbot Grok praises Hitler on X
Speed Read Grok made antisemitic comments and referred to itself as 'MechaHitler'
-
Disney, Universal sue AI firm over 'plagiarism'
Speed Read The studios say that Midjourney copied characters from their most famous franchises
-
Amazon launches 1st Kuiper internet satellites
Speed Read The battle of billionaires continues in space
-
Test flight of orbital rocket from Europe explodes
Speed Read Isar Aerospace conducted the first test flight of the Spectrum orbital rocket, which crashed after takeoff